Publikationen (32) Publikationen von JEZABEL RODRIGUEZ BLANCO

2024

  1. Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells

    International journal of oncology, Vol. 64, Núm. 1

  2. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer

    Cell Death and Differentiation, Vol. 31, Núm. 7, pp. 881-896

  3. Mechanistic insights into medulloblastoma relapse

    Pharmacology and Therapeutics, Vol. 260

  4. Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models

    The Journal of clinical investigation, Vol. 134, Núm. 15

2022

  1. A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog–Dependent Tumor Growth

    Molecular Cancer Research, Vol. 20, Núm. 11, pp. 1598-1610

  2. Noncanonical activation of GLI signaling in SOX2+ cells drives medulloblastoma relapse

    Science Advances, Vol. 8, Núm. 29

  3. Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression

    Neuro-Oncology Advances, Vol. 4, Núm. 1

2021

  1. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration

    Journal of Cellular Physiology, Vol. 236, Núm. 1, pp. 27-40

2020

  1. Epigenetic pathways and plasticity in brain tumors

    Neurobiology of Disease, Vol. 145

  2. Role of glucose metabolism in the differential antileukemic effect of melatonin on wild-type and FLT3-ITD mutant cells

    Oncology Reports, Vol. 44, Núm. 1, pp. 293-302

2019

  1. A CK1a Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma

    Clinical Cancer Research, Vol. 25, Núm. 4, pp. 1379-1388

  2. Time series modeling of cell cycle exit identifies Brd4 dependent regulation of cerebellar neurogenesis

    Nature Communications, Vol. 10, Núm. 1

2017

  1. Differential abundance of CK1a provides selectivity for pharmacological CK1a activators to target WNT-dependent tumors

    Science Signaling, Vol. 10, Núm. 485

  2. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma

    Oncogene, Vol. 36, Núm. 45, pp. 6306-6314

2013

  1. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells

    International Journal of Molecular Sciences, Vol. 14, Núm. 4, pp. 6597-6613

2012

  1. Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells

    Journal of Neuroscience Research, Vol. 90, Núm. 9, pp. 1850-1860

  2. Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

    British Journal of Cancer, Vol. 106, Núm. 7, pp. 1288-1296

2011

  1. Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells

    Free Radical Research, Vol. 45, Núm. 11-12, pp. 1333-1341

  2. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients

    Journal of Pineal Research, Vol. 50, Núm. 3, pp. 345-355

2010

  1. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death

    Cancer Letters, Vol. 287, Núm. 2, pp. 216-223